tiprankstipranks
Spero Therapeutics (SPRO)
NASDAQ:SPRO
US Market
SPRO
Spero Therapeutics
RESEARCH TOOLSreports

Spero Therapeutics (SPRO) Financial Statements

585 Followers

Spero Therapeutics Financial Overview

Spero Therapeutics's market cap is currently $160.94M. The company's EPS TTM is $0.53; its P/E ratio is 15.23; Spero Therapeutics is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Mar 22
Income Statement
Total Revenue$ 59.62M$ 47.98M$ 103.78M$ 48.58M$ 3.07M
Gross Profit$ 59.62M$ -48.78M$ 52.34M$ 48.58M$ 3.07M
Operating Income$ -24.00K$ -73.36M$ 21.48M$ -42.20M$ -87.97M
EBITDA$ -24.00K$ -72.48M$ 27.15M$ -42.94M$ -87.17M
Net Income$ 8.57M$ -68.57M$ 22.81M$ -46.41M$ -89.76M
Balance Sheet
Cash & Short-Term Investments$ 40.27M$ 52.89M$ 76.33M$ 109.11M$ 146.40M
Total Assets$ 68.92M$ 110.54M$ 182.39M$ 124.80M$ 171.07M
Total Debt$ 2.90M$ 4.30M$ 5.54M$ 6.65M$ 7.33M
Net Debt$ -37.37M$ -48.59M$ -70.79M$ -102.46M$ -105.25M
Total Liabilities$ 9.90M$ 64.42M$ 75.50M$ 48.87M$ 82.78M
Stockholders' Equity$ 59.02M$ 46.12M$ 106.89M$ 75.93M$ 88.29M
Cash Flow
Free Cash Flow$ -12.62M$ -23.44M$ -32.99M$ -7.73M$ 0.00
Operating Cash Flow$ -12.62M$ -23.44M$ -32.99M$ -7.73M$ -64.35M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 33.81M$ 7.67M
Financing Cash Flow$ 0.00$ 0.00$ 221.00K$ -29.55M$ 84.05M
Currency in USD

Spero Therapeutics Earnings and Revenue History

Income Statement >

Spero Therapeutics Debt to Assets

Balance Sheet >

Spero Therapeutics Cash Flow

Cash Flow >

Spero Therapeutics Forecast EPS vs Actual EPS

Earnings >